Concentrix cuts FY2026 sales guidance, narrows EPS outlook; Q4 guidance below estimates

Concentrix lowered FY2026 sales guidance to $9.827B-$9.877B from $9.925B-$10.025B and narrowed adjusted EPS guidance to $10.97-$11.09, versus consensus of $10.015B and $11.38. It guided Q4 adjusted EPS to $2.86-$2.98 and sales to $2.410B-$2.460B, both below estimates.

Detected & updated continuously · Source: Nebula